Showing results (381-390 of 892) with videos related to
Sort By:
Pageof 90
Diabetes Care|July 7, 2022
Heart Failure: An Underappreciated Complication of Diabetes. A Consensus Report of the American Diabetes AssociationRodica Pop-Busui, James L Januzzi, Dennis Bruemmer, et al.Journal of the American College of Cardiology|August 4, 2022
Cardiovascular Disease Projections in the United States Based on the 2020 Census EstimatesReza Mohebi, Chen Chen, Nasrien E Ibrahim, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|June 18, 2016
Circulating Proneurotensin Concentrations and Cardiovascular Disease Events in the Community: The Framingham Heart StudyJames L Januzzi, Asya Lyass, Yuyin Liu, et al.Journal of the American College of Cardiology|February 4, 2022
Stress Cardiac Biomarkers, Cardiovascular and Renal Outcomes, and Response to CanagliflozinMuthiah Vaduganathan, Naveed Sattar, Jialin Xu, et al.Journal of the American College of Cardiology|March 25, 2022
Mineralocorticoid Receptor Antagonists and Empagliflozin in Patients With Heart Failure and Preserved Ejection FractionJoão Pedro Ferreira, Javed Butler, Faiez Zannad, et al.Clinical Chemistry|June 16, 2011
Copeptin does not add diagnostic information to high-sensitivity troponin T in low- to intermediate-risk patients with acute chest pain: results from the rule out myocardial infarction by computed tomography (ROMICAT) studyMahir Karakas, James L Januzzi, Julia Meyer, et al.Critical Care Medicine|August 3, 2004
Utility of B-type natriuretic peptide for the evaluation of intensive care unit shockRoderick H Tung, Christine Garcia, Alexander M Morss, et al.European Heart Journal|February 12, 2008
Usefulness of clinical and NT-proBNP monitoring for prognostic guidance in destabilized heart failure outpatientsDomingo A Pascual-Figal, Maite Domingo, Teresa Casas, et al.JACC. Heart Failure|March 5, 2023
Recency of Heart Failure Hospitalization, Outcomes, and the Effect of Empagliflozin: An EMPEROR-Pooled AnalysisJoão Pedro Ferreira, Faiez Zannad, Javed Butler, et al.Journal of the American College of Cardiology|October 30, 2020
Effects of Canagliflozin on Amino-Terminal Pro-B-Type Natriuretic Peptide: Implications for Cardiovascular Risk ReductionJames L Januzzi, Jialin Xu, JingWei Li, et al.Pageof 90